NCT05797246 2026-01-26Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)National Institutes of Health Clinical Center (CC)Phase 2 Active not recruiting21 enrolled
NCT04198766 2025-12-18Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Inhibrx Biosciences, IncPhase 1/2 Active not recruiting296 enrolled
NCT05617755 2025-07-30AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian CancerArsenal Biosciences, Inc.Phase 1 Active not recruiting19 enrolled